Alpha-synuclein propagation: New insights from animal models.
about
Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's diseaseTransmission of α-synucleinopathy from olfactory structures deep into the temporal lobe.Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's DiseaseThe Bcl-2 homologue Buffy rescues α-synuclein-induced Parkinson disease-like phenotypes in Drosophila.Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson's diseaseCurrent disease modifying approaches to treat Parkinson's disease.Targeting α-synuclein: Therapeutic options.Oligomeropathies and pathogenesis of Alzheimer and Parkinson's diseases.Multiple system atrophy: pathogenic mechanisms and biomarkers.The c-Abl inhibitor in Parkinson disease.Multiple system atrophy: insights into a rare and debilitating movement disorder.Degeneration of rapid eye movement sleep circuitry underlies rapid eye movement sleep behavior disorder.Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3.Biomarker Research in Parkinson's Disease Using Metabolite Profiling.In vivo models of alpha-synuclein transmission and propagation.Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson's disease.Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease.Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.Potential clinical utility of multiple system atrophy biomarkers.Multiple System Atrophy: An Oligodendroglioneural Synucleinopathy.Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.Understanding the Role of Adenosine A2AR Heteroreceptor Complexes in Neurodegeneration and Neuroinflammation.Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration.Proteasome-targeted nanobodies alleviate pathology and functional decline in an α-synuclein-based Parkinson's disease model
P2860
Q26773485-DA831EAD-D973-43F0-A34A-8931EBB43E6FQ27301056-6A25D0E4-7787-4C12-8498-BE6B261DF7CFQ28078561-043C43C7-FE58-4231-97CD-1418EF465C4CQ30359012-CC70A834-AA25-427C-A79A-9FB0DFAD4621Q37197984-E898AFC6-913C-4DF4-8454-3C127A6852BAQ38652153-A5E40F7B-F2DB-4663-A7EF-6B6DACD4E8C5Q38754587-5DA12536-E5D4-46DA-9EAC-BCD9DA615EC2Q38794219-DA9FF2BF-BB7B-41E8-B8D9-025D5E2FF8F7Q38813304-B8818157-CECD-4768-A48B-A8AE4BF0D006Q39081447-172CA626-EDB3-4798-A94F-DB87BE0DAD12Q39183459-ED6EB6FC-130B-41D6-ABAD-121C2EC43F2FQ39231424-306EB8A4-2CC8-4DA0-A731-567777AC8A5BQ41015843-B42A4240-9B65-4AF9-9439-D58A23E78CA9Q41666702-0EB79ABB-4B31-4166-A263-38CD83A23356Q46252300-6C20258B-C828-4AAB-9F90-459C8AE9F256Q46354756-6A3848A7-5BDD-47A2-BB44-F6E23B842BCCQ47123483-7174373A-3911-42C3-9D0B-D783DEF60632Q47259722-D2C0E59E-C2C4-40FC-922B-3FC631991B37Q47361450-DAC93C32-B70C-4E62-A11E-2C5EC41A1EC9Q47663712-0DA4826C-4681-4F43-AF21-8DA42A0898C3Q49562668-0AD509BE-3793-4D4F-8F49-538D7BDF9885Q50109111-E115A4F8-D1B8-479D-9ADE-B4B8FDD867F6Q50284399-8F15B5FB-4A1C-4EBC-872A-C926944186B5Q54916848-1C6167CB-A245-47EE-911A-12706D3C2010Q58722552-644DE58C-7667-47F4-BC58-A101FAB99692
P2860
Alpha-synuclein propagation: New insights from animal models.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Alpha-synuclein propagation: New insights from animal models.
@en
type
label
Alpha-synuclein propagation: New insights from animal models.
@en
prefLabel
Alpha-synuclein propagation: New insights from animal models.
@en
P2860
P50
P356
P1433
P1476
Alpha-synuclein propagation: New insights from animal models.
@en
P2093
Benjamin Dehay
P2860
P304
P356
10.1002/MDS.26370
P407
P577
2015-09-08T00:00:00Z